Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2016
Total Assets: $2.90B
Liabilities Breakdown FY2016
Total Liabilities: $1.56B
Asset Breakdown
Total Assets: $2.90B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.18B | 40.9% |
| Accounts Receivable | $200.4M | 6.9% |
| Inventory | $77.6M | 2.7% |
| Property, Plant & Equipment | $698.4M | 24.1% |
| Goodwill | $50.4M | 1.7% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $686.1M | 23.7% |
Liabilities Breakdown
Total Liabilities: $1.56B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $61.5M | 3.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.50B | 96.1% |